Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brakenhoff

Showing results (281-290 of 460) with videos related to

Pageof 46
Sort By:
Nederlands Tijdschrift Voor Tandheelkunde|February 19, 2021
[Identification of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression]L J Wils, J B Poell, I Evren, et al.
International Journal of Molecular Medicine|February 22, 2008
Genome-wide microarray gene expression, array-CGH analysis, and telomerase activity in advanced ovarian endometriosis: a high degree of differentiation rather than malignant potentialMenelaos Zafrakas, Basil C Tarlatzis, Thomas Streichert, et al.
Plos One|April 25, 2013
DNA-bound platinum is the major determinant of cisplatin sensitivity in head and neck squamous carcinoma cellsSanne R Martens-de Kemp, Simone U Dalm, Fiona M J Wijnolts, et al.
Oral Oncology|November 2, 2015
HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs?Robert P Takes, Małgorzata Wierzbicka, Gypsyamber D'Souza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implicationsM P Tabor, R H Brakenhoff, V M van Houten, et al.
Journal of Proteomics|February 3, 2019
Proteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response predictionFranziska Böttger, Tieneke B Schaaij-Visser, Inge de Reus, et al.
International Journal of Cancer|February 26, 2021
The unveiled reality of human papillomavirus as risk factor for oral cavity squamous cell carcinomaIrene H Nauta, Daniëlle A M Heideman, Arjen Brink, et al.
British Journal of Cancer|May 8, 2015
Different prognostic models for different patient populations: validation of a new prognostic model for patients with oropharyngeal cancer in Western EuropeM M Rietbergen, B I Witte, E R Velazquez, et al.
European Journal of Internal Medicine|May 8, 2022
Hepatitis C Elimination in the Netherlands (CELINE): How nationwide retrieval of lost to follow-up hepatitis C patients contributes to micro-eliminationCas J Isfordink, Marleen van Dijk, Sylvia M Brakenhoff, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 12, 2014
A comprehensive assessment protocol including patient reported outcomes, physical tests, and biological sampling in newly diagnosed patients with head and neck cancer: is it feasible?Annette J van Nieuwenhuizen, Laurien M Buffart, Jan H Smit, et al.
Pageof 46

Showing results (281-290 of 460) with videos related to

Sort By:
Pageof 46
Nederlands Tijdschrift Voor Tandheelkunde|February 19, 2021
[Identification of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression]L J Wils, J B Poell, I Evren, et al.
International Journal of Molecular Medicine|February 22, 2008
Genome-wide microarray gene expression, array-CGH analysis, and telomerase activity in advanced ovarian endometriosis: a high degree of differentiation rather than malignant potentialMenelaos Zafrakas, Basil C Tarlatzis, Thomas Streichert, et al.
Plos One|April 25, 2013
DNA-bound platinum is the major determinant of cisplatin sensitivity in head and neck squamous carcinoma cellsSanne R Martens-de Kemp, Simone U Dalm, Fiona M J Wijnolts, et al.
Oral Oncology|November 2, 2015
HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs?Robert P Takes, Małgorzata Wierzbicka, Gypsyamber D'Souza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implicationsM P Tabor, R H Brakenhoff, V M van Houten, et al.
Journal of Proteomics|February 3, 2019
Proteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response predictionFranziska Böttger, Tieneke B Schaaij-Visser, Inge de Reus, et al.
International Journal of Cancer|February 26, 2021
The unveiled reality of human papillomavirus as risk factor for oral cavity squamous cell carcinomaIrene H Nauta, Daniëlle A M Heideman, Arjen Brink, et al.
British Journal of Cancer|May 8, 2015
Different prognostic models for different patient populations: validation of a new prognostic model for patients with oropharyngeal cancer in Western EuropeM M Rietbergen, B I Witte, E R Velazquez, et al.
European Journal of Internal Medicine|May 8, 2022
Hepatitis C Elimination in the Netherlands (CELINE): How nationwide retrieval of lost to follow-up hepatitis C patients contributes to micro-eliminationCas J Isfordink, Marleen van Dijk, Sylvia M Brakenhoff, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 12, 2014
A comprehensive assessment protocol including patient reported outcomes, physical tests, and biological sampling in newly diagnosed patients with head and neck cancer: is it feasible?Annette J van Nieuwenhuizen, Laurien M Buffart, Jan H Smit, et al.
Pageof 46